Nei Regenerative Medicine Clinical Trial Planning Grant (R34 Tender
Notice for Nei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed) in USA. The reference ID of the tender is 64125056 and it is closing on 07 May 2025.
Tender Details
- Country: USA
- Summary: Nei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed)
- UST Ref No: 64125056
- Deadline: 07 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-135
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
CFDA Number : 93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: May 07, 2025
Posted Date : Mar 08, 2022
Description: The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research specifically targets photoreceptors (PRCs) and retinal ganglion cells (RGCs) in the eye. Photoreceptors often called rods and cones are cells in the retina that, when stimulated by light, generate signals the brain perceives as images. The retinal ganglion cells carry these signals from the photoreceptors to the brain. Although there has been some success in regenerating retinal neurons and connections in fish, mice, and other systems, the ultimate goal of the AGI is to restore vision in humans. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed). This tender is published on USARFP under UST Ref No: 64125056 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.
- 1,000+ Tenders
- Verified Tenders Only
- New Tenders Every Day
- Tenders Result Data
- Archive & Historical Tenders Access
- Consultants for RFI/RFP/RFQ
- Tender Notifications & Alerts
- Search, Sort, and Filter Tenders
- Bidding Assistance & Consulting
- Customer Support
- Publish your Tenders
- Export data to Excel
- API for Tender Data
- Tender Documents
Fill out the form below and you will receive a call from us within 24 hours.
Get FREE SAMPLE TENDERS from USA in your email inbox.
Copyright © 2014-2026 USARFP.com. All Rights Reserved.


